Manchester University NHS Foundation Trust (MFT) invites you to the launch of the MFT Diagnostics and Technology Accelerator (DiTA) on Thursday 7th February 2019.

What is DiTA?

The MFT DiTA initiative is led by a diverse multidisciplinary team of clinicians and methodologists, directed by Professor Rick Body, Professor and Honorary Consultant in Emergency Medicine, to catalyse the generation of evidence for commercially supplied in vitro diagnostics and medical technology.

It is an exciting opportunity to bring together patients, clinicians, researchers, commissioners and industry to generate the research evidence required to fast-track new devices and technologies into clinical practice.

Why attend?

Open to industry, researchers, clinicians and potential national partners, this event will be an opportunity for you to find out more about the MFT DiTA and how the initiative fits with the wider Greater Manchester landscape.

For industry participants, the benefits of attendance include the opportunity to:

• Access specific support to enable you to generate the evidence base to bring a product to the NHS market
• Hear about funding opportunities available from the DiTA initiative and Innovate UK
• Meet potential collaborators, based in the UK’s largest clinical academic campus
• Input into future activities, to tailor DiTA support to industry needs.

Confirmed speakers and participation from Innovate UK, National Institute of Health and Care Excellence (NICE), British In Vitro Diagnostics Association (BIVDA) and Health Innovation Manchester.

Find out more about DiTA – https://research.cmft.nhs.uk/partnering/dita

Email questions to: dita@mft.nhs.uk

AGENDA:

9.30 – 10.00       Arrival, registration, coffee

Session 1            Translating innovative technology into practice

Chair: Rowena Burns, Manchester Science Partnerships

10.00 – 10.30     Welcome to DiTA – our mission

Rick Body, Director, DiTA

Katherine Boylan, Ops Director, DiTA

10.30 – 10.45     Extreme Collaboration  (Title TBC)

Ben Bridgewater, CEO, Health Innovation Manchester

10.45 – 11.15     The importance of collaboration for industry (Title TBC)

Chris Hudson, Director, Health Care Development & Strategic Services, Roche Diagnostics

11.15 – 11.35    Coffee, networking, breakout, marketplace

11.35 – 12.30     Effective Collaboration with Industry – a panel discussion 

Chairs: Rick Body & Katherine Boylan

Ben Bridgewater, CEO, Health Innovation Manchester

Jayne Ellis, Head of Market Development and Medical Affairs, LumiraDx

Chris Hudson, Director, Health Care Development & Strategic Services, Roche Diagnostics

Linda Magee, NHS Sector Specialist, Life Sciences Organisation, Department for International Trade

Richard Phillips, Director, Healthcare Policy, Association of British HealthTech Industries

Doris-Ann Williams, Chief Executive, British In Vitro Diagnostics Association

12.30 – 1.15       Lunch, networking, breakout, marketplace

Session 2            Support and opportunities                                                                 

Chair: Hakim Yadi, CEO, Northern Health Science Alliance

1.15 – 1.30         Opportunities from Innovate UK (Title TBC)

Kath Mackay, interim Director of Ageing Society, Health & Nutrition, Innovate UK

1.30 – 1.45         The NICE perspective (Title TBC)

Sarah Byron, Associate Director, Diagnostics Assessment Programme, NICE

1.45 – 2.00         The NIHR Medtech Offer to Industry

Ravi Chana, Business Development, NIHR Office for Clinical Research Infrastructure

2.00 – 2.15         How DiTA can help you

Rick Body, Director, Diagnostics and Technology Accelerator

2.15 – 2.30         Q&A session

2.30                     Close of formal proceedings – The DiTA team will be around for further individual discussions from 2.30pm